Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells. - Wikidata - awgldk - TriplyDB

Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

http://www.wikidata.org/entity/Q36677847

about

Identifying and targeting tumor-initiating cells in the treatment of breast cancer Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer Involvement of inflammation and its related microRNAs in hepatocellular carcinoma p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling Chronic inflammation and cytokines in the tumor microenvironment.Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis.Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.Breast cancer stem cells.A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.Effect of niclosamide on basal-like breast cancers.Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Radiation treatment and cancer stem cells.Cancer stem cells and personalized cancer nanomedicine.Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.Endothelial cells activate the cancer stem cell-associated NANOGP8 pathway in colorectal cancer cells in a paracrine fashion SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells.Enhanced Directional Migration of Cancer Stem Cells in 3D Aligned Collagen Matrices.Role of interleukin-6 in cancer progression and therapeutic resistance.CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.

P2860

Q26851827-6D5E0F0C-9AA5-40A8-90DE-83CE5D35287D Q26991480-339BCEA7-2233-4615-B369-AC7B5B44228E Q27023599-7FDCF2E5-6F34-4D56-AD9D-4D8FCF6B53B9 Q28079138-D1A9ADF2-9640-4A69-879E-C2796BD802F3 Q28269527-71395F2A-7F2C-464B-9732-CC63B2236090 Q28535709-840BBDF7-C109-4D57-BA4B-80412D58A516 Q28553202-F0D0D694-685E-41AD-BFC5-B7B6E7B277E2 Q30805174-5FA4A579-8E7D-4E0A-B13A-288EABEF27FC Q33559947-C635E50F-2267-4EFD-8286-6BBAE2C9AEE1 Q33678275-D681D103-47BF-458C-BCBD-0C8B4740B34A Q33820278-64A6A547-BE4F-4EB7-A396-8112FD174874 Q34199032-4C977379-6180-4A58-A30A-0DBCEEBFB121 Q35605854-1BA932E3-9CB4-4A02-9397-34F58931A70D Q35752008-CC21BE41-5581-443E-9776-E7A434F60875 Q35772708-B7923120-3FD6-4838-A8C9-D6C0A8406111 Q35817986-42F40423-A2C7-435B-B7E4-2AD5692E5DF8 Q35830305-7EC959E6-B9E5-4809-BF53-24E44F24D38B Q36150377-61CD2521-7DD1-412C-BBCE-DED731499E81 Q36194212-7C99FCAC-F530-40DB-A931-91304A67EA73 Q36356086-66B6FE1C-4FB7-4FA3-AB1C-C93A02AE236B Q36399064-98A419F3-6115-4055-9891-2BF59D6CF506 Q36528333-267A8B63-B724-4EAF-ACD5-1AB8A9E358AF Q36962901-D0959753-2A57-41A3-8A85-D0898BFA1200 Q37121784-332A7EAE-546E-4615-9927-8F71F19562F7 Q37189154-16CC9F86-4EDA-408C-A719-F6F0DD5663D9 Q37390759-7E803D08-6507-450C-9414-02E1378114FA Q37536623-8412AF93-6F86-4B9A-9360-1CA775DABAA2 Q37695022-854CCF49-C4F7-4BC5-9089-267D52A3B6F2 Q37722551-5903FF10-170F-4DF4-81A5-648F0BE6FAAE Q38194970-0DFE453A-D041-49B5-9F50-EA3FDE455537 Q38203779-A336C4F7-7ECE-445E-9ABE-EA11561815E5 Q38331970-34AEF2D2-B203-49CE-A1C6-79F18EF35FFA Q38702970-9DB5D776-65D4-4D3F-B307-BD5DD790FB46 Q38704813-6079EE36-8A6B-43B0-AACD-1853B86F503F Q38705707-B240A212-7AEE-4550-A67C-D6BBA0E63B6E Q38709877-3B864B05-2BC3-4D45-910C-E38525DB0A11 Q38712173-6C585D58-710A-44AA-B672-FF1E1F69D9F6 Q38853625-60A34A49-AC1B-4BE1-9CC7-DBEFCCED8E11 Q38900723-BC396A6A-2269-4464-98E9-51E7B251C33A Q38902610-7B0C258F-59CF-431D-9B4D-7E5359A863C0

P2860

Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

http://www.wikidata.org/entity/Q36677847

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@ast

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@en

type

label

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@ast

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@en

prefLabel

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@ast

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@en

P1433

Q36677847-D68E88F5-5F90-437B-A03A-20FBD735AB25

P1476

Q36677847-B8389933-2E7F-4B7B-A348-FBC7EC791385

P2093

Q36677847-01960826-E9F2-4959-9506-5A97BA05710D

Q36677847-0D65F887-B4EF-402A-A497-CFB7884B5F75

Q36677847-1F6755B4-473D-4F81-AA43-FE285D368FE1

Q36677847-33EDAB3D-FD24-4731-BA18-984DE15E0427

Q36677847-3AC586A6-C3E8-4570-B5D9-42702FB82CD7

Q36677847-6055FE5B-3B04-488F-B8E2-6BE08C29D61C

Q36677847-8896F04D-9174-41A8-B36F-DB263F08B639

P2860

Q36677847-0279B98D-1C71-44A2-8972-9B0FE70D96B6

Q36677847-02D82D6A-4920-4827-A828-12FBD56099A7

Q36677847-076D98E2-1DEB-4A39-906A-33783211FBD7

Q36677847-07B3BA02-5192-422C-8D73-826A4C237C67

Q36677847-0DBD8FF8-CDCF-4563-B5B8-E74FCFD78648

Q36677847-1454DF48-3593-488D-84CF-10BD70A54ACC

Q36677847-154F5A64-36AA-4FF7-B373-6EE91E04DF0F

Q36677847-1A99D355-B48B-473F-A7EF-5AE8A56342AB

Q36677847-22D0B931-78F1-42A4-B53F-53702C621F13

Q36677847-289E44CC-D283-458B-9D04-C6CBE4B355BC

P304

Q36677847-1612BF50-3DDF-412F-A5A6-B75E0AF68339

P31

Q36677847-441EC8C3-36B8-46B5-8DFE-5B31F944A616

P356

Q36677847-DE484482-8E1B-4103-82D1-3A8044124C1A

P433

Q36677847-7775848D-F8B4-4A5A-8384-F3A8EEE38086

P478

Q36677847-86A13E70-0DF1-407C-A247-334EEB97A590

P577

Q36677847-9465E409-15F0-48AA-92C8-518927C5C343

P5875

Q36677847-8AC2B929-8592-4ABD-8A38-C03E34DFF1A4

P698

Q36677847-C7E16758-2DAA-4C5C-82B5-39D4B83BB55B

P932

Q36677847-10A696DD-07C4-4AEE-A413-FC0580915EFF

P356

J.CELLSIG.2013.01.007

P1433

Cellular Signalling

P1476

Role of the IL-6-JAK1-STAT3-Oc ...... s into cancer stem-like cells.

@en

P2093

Bo Kyoung Kim

http://www.w3.org/2001/XMLSchema#string

Jin Wook Kang

http://www.w3.org/2001/XMLSchema#string

Seog-Young Kim

http://www.w3.org/2001/XMLSchema#string

Xinxin Song

http://www.w3.org/2001/XMLSchema#string

Yong J Lee

http://www.w3.org/2001/XMLSchema#string

Yong Tae Kwon

http://www.w3.org/2001/XMLSchema#string

Young Dong Yoo

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

Activation and association of Stat3 with Src in v-Src-transformed cell lines

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

Prospective identification of tumorigenic breast cancer cells

Cancer statistics, 2012

A genetic model for colorectal tumorigenesis

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Identification of human brain tumour initiating cells

P304

961-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELLSIG.2013.01.007

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234699505

http://www.w3.org/2001/XMLSchema#string

P698

23333246

http://www.w3.org/2001/XMLSchema#string

P932

3595341

http://www.w3.org/2001/XMLSchema#string